Learning Amyloid and Tau Results

Part of paid clinical trials in Madison, Wisconsin.

Sponsor
University of Wisconsin, Madison
Study ID
NCT07222930
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 89 Years
Healthy Volunteers
Accepted

Interventions

  • Disclose amyloid, tau results — OTHER
    Release of results from investigational agents conducted under IND 107114, IND 166860, and IND 134516
  • Follow-up Assessments — OTHER
    self-report psychosocial and behavioral questionnaires

Study Details

This is a prospective, single-cohort, single-center, observational study to assess if learning one's Alzheimer's disease biomarker test result impacts longitudinal psychosocial, behavioral, and neuropsychological outcomes, and to identify factors that moderate and mediate these outcomes. Participants enrolled in this study are requested to complete surveys at four timepoints after learning their Alzheimer's biomarker test results.

Key Dates

Start date
Feb 17, 2026
Status verified
May 2026
Primary completion
Jun 30, 2029
Completion
Jun 30, 2029

Study Design

Enrollment
240 participants (estimated)

Arms

  • Arm: Participants from UW Alzheimer's Disease Research
    Participants aged 50-89 who are cognitively unimpaired or have mild cognitive impairment will be enrolled from the Wisconsin Registry for Alzheimer's Prevention, Wisconsin Alzheimer's Disease Research Center Clinical Core, or other studies affiliated with the UW Alzheimer's Research Program.

Primary Outcome Measure

Impact of Neuroimaging in Alzheimer's Disease (INI-AD) Score [ Time Frame: 1 month, 6 months, 12 months, 18 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of WisconsinMadisonWisconsin53792-

Find similar trials in Madison, WI

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
University of Wisconsin· Madison, WI

Related Studies